Dhansa Labs Peer Comparison

NSE: AMBEY

₹26.00

₹1.20 (4.84%)

As on 28-Aug-2026IST

Market cap

₹70 Cr

Revenue (TTM)

₹131 Cr

P/E Ratio

12.7

P/B Ratio

--

Div. Yield

0 %

Edit

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Market cap (₹ Cr)	70	19,006	15,936	14,332	7,891
Revenue (₹ Cr)	131	6,643	14,593	38,840	10,312
Net Profit (₹ Cr)	4.78	804.37	1,434.33	1,227.53	267.94
Net Margin (%)	3.59	11.74	9.69	3.14	2.60
RoE (%)	11.01	13.10	16.37	16.62	11.90
Price to Earnings	12.67	23.89	11.12	30.83	24.95
Price-To-Book	--	2.94	1.90	1.58	2.62

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Operating Revenue	131.27	5,583.35	12,077.35	31,608.61	3,768.26
Total Income	133.19	5,692.38	12,226.59	32,047.76	3,784.18
Total Expenditure	121.65	4,670.39	10,754.19	29,001.39	3,257.32
EBITDA	9.62	912.96	1,323.16	2,607.22	510.94
Depreciation	2.54	316.82	410.17	512.39	115.20
EBIT	7.07	596.14	912.99	2,094.83	395.74
Interest	2.95	23.98	152.82	372.43	165.74
Other Income	1.92	109.03	149.24	439.15	15.92
Exceptional Items	--	--	--	346.77	--
Profit before Tax	6.04	692.49	909.41	2,454.59	292.32
Provision for Tax	1.26	193.66	305.14	682.05	61.40
Profit after Tax	4.78	498.83	604.27	1,772.54	230.92

Liabilities (₹ Cr)

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Shareholder's Funds	76.35	5,598.55	7,004.13	7,935.73	2,255.88
Minority Interest	--	63.82	--	4,995.79	--
Non-Current Liabilities	9.86	435.84	2,483.85	1,044.59	1,599.18
Current Liabilities	39.58	1,036.89	5,280.02	10,394.98	2,321.04
Total Liabilities	127.21	7,135.10	14,774.14	24,371.09	6,176.10

Assets (₹ Cr)

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Non-Current Assets	39.26	4,037.12	7,617.51	8,052.50	4,359.88
Current Assets	86.53	3,097.98	7,136.18	16,318.37	1,816.22
Total Assets	127.21	7,135.10	14,774.14	24,371.09	6,176.10
Total Debt*	40.84	197.69	2,408.19	2,121.01	1,804.27
Net Current Assets	46.95	2,061.09	1,856.16	5,923.39	-504.82
Contingent Liabilities	13.82	162.18	19.49	459.30	41.24

Cashflow (₹ Cr)

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Cash From Operating Activities	-34.48	603.13	1,126.96	1,936.39	362.11
Cash Flow from Investing Activities	-13.50	-495.09	-849.80	-2,782.30	-735.99
Cash from Financing Activities	48.34	-117.78	-0.53	73.84	353.75
Net Cash Inflow / Outflow	0.36	-9.74	276.63	-772.07	-20.12

Ratios

Profitability Ratios

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
ROCE (%)	11.43	12.86	11.79	30.76	12.33
ROE (%)	11.01	9.31	8.94	23.70	10.72
ROA (%)	4.72	7.27	4.28	7.73	3.92
EBIT Margin (%)	8.79	18.30	12.19	9.64	13.98
Net Margin (%)	3.59	8.76	4.94	5.53	6.10
Cash Profit Margin (%)	5.58	14.28	7.74	7.23	3.83

Growth Ratios

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Revenue Growth (%)	8.96	18.15	10.57	7.46	14.40
EBIT Growth (%)	8.11	47.07	35.18	4.35	22.27
Net Profit Growth (%)	-38.06	53.90	35.15	9.58	33.49
EPS Growth (%)	-53.60	49.81	35.15	-2.53	33.49
Book Value Growth (%)	213.38	9.47	7.39	12.47	9.99

Valuation Ratios

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Price / Earnings	20.97	37.31	27.75	15.90	7.44
Price / Book Value	1.52	3.23	2.39	1.76	1.52
Dividend Yield (%)	0.00	0.41	0.84	0.00	0.90
EV/EBITDA	12.08	17.80	12.35	4.07	9.80
Market Cap (₹ Cr)	100.29	18,057.11	16,766.99	13,964.68	3,437.03

Solvency Ratios

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Debt to Equity	0.62	0.04	0.34	0.27	0.80
Short term debt to equity ratio	--	0.00	0.12	0.22	0.20
Current Ratio	2.19	2.99	1.35	1.57	0.78
Quick Ratio	1.43	2.28	0.82	0.93	0.28
Interest Coverage	3.05	29.88	6.95	7.59	2.76

Operating Efficiency Ratios

	Dhansa Labs	Atul	DCM Shriram	EID Parry	India Glycols
Debtors to sales (%)	30.80	20.17	7.61	5.56	9.69
Asset Turnover	1.30	0.83	0.93	1.38	1.53
Receivable days	82.19	65.62	21.80	20.74	15.12
Inventory Days	70.19	43.06	76.27	78.72	45.98
Payable days	33.43	79.37	64.58	39.02	185.71
Cash Conversion Cycle	118.95	29.31	33.49	60.44	-124.61